Infections in pediatric postdiarrheal hemolytic uremic syndrome: Factors associated with identifying Shiga toxin-producing Escherichia coli

Archives of Pediatrics and Adolescent Medicine

Volumn 166, Issue 10, 2012, Pages 902-909

  Mody, Rajal K ^a   Luna Gierke, Ruth E ^a   Jones, Timothy F ^b   Comstock, Nicole ^c   Hurd, Sharon ^d   Scheftel, Joni ^e   Lathrop, Sarah ^f   Smith, Glenda ^g   Palmer, Amanda ^h   Strockbine, Nancy ^a   Talkington, Deborah ^a   Mahon, Barbara E ^a   Hoekstra, Robert M ^a   Griffin, Patricia M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c Air Pollution Control Division   (United States)

^d Connecticut Emerging Infections Program ^*  (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f New Mexico Emerging Infections Program   (United States)

^g New York State Emerging Infections Program   (United States)

^h MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ANEMIA; ARTICLE; BLOODY DIARRHEA; CHILD; CLINICAL PRACTICE; DEMOGRAPHY; ESCHERICHIA COLI INFECTION; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HEALTH SURVEY; HEMATOCRIT; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGA TOXIN PRODUCING ESCHERICHIA COLI INFECTION; SHIGELLOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIARRHEA; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INCIDENCE; INFANT; INFECTION CONTROL; MALE; PNEUMOCOCCAL INFECTIONS; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; SEROLOGIC TESTS; SHIGA-TOXIGENIC ESCHERICHIA COLI; UNITED STATES;

EID: 84867123391     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2012.471     Document Type: Article

References (48)

1. Gould LH, Demma L, Jones TF, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis. 2009;49(10):1480-1485.
2. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365(9464):1073-1086. (Pubitemid 40386785)
3. Centers for Disease Control and Prevention (CDC). Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep. 2011;60(22):749-755.
4. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis. 2011;17(1):7-15.
5. Gould LH, Bopp C, Strockbine N, et al Centers for Disease Control and Prevention (CDC). Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep . 2009;58(RR-12):1- 14.
6. Hoefer D, Hurd S, Medus C, et al; Emerging Infections Program FoodNet Working Group. Laboratory practices for the identification of Shiga toxin-producing Escherichia coli in the United States, FoodNet sites, 2007. Foodborne Pathog Dis. 2011; 8(4):555-560.
7. Stigi KA, Macdonald JK, Tellez-Marfin AA, Lofy KH. Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections. Emerg Infect Dis. 2012;18(3):477-479.
8. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol. 2002;155(10):941- 948.
9. Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics. 1994;94 (1):35-40. (Pubitemid 24194093)
10. Tarr PI, Hickman RO. Hemolytic uremic syndrome epidemiology: a populationbased study in King County, Washington, 1971 to 1980. Pediatrics . 1987;80(1): 41-45. (Pubitemid 17091734)
11. Genese CA, Brook J, Spitalny K. Hemolytic uremic syndrome in New Jersey. N J Med. 1995;92(1):29-32.
12. Kinney JS, Gross TP, Porter CC, Rogers MF, Schonberger LB, Hurwitz ES. Hemolyticuremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland. Am J Public Health. 1988;78(1):64-65. (Pubitemid 18030014)
13. Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med. 1990;323(17):1161-1167. (Pubitemid 20347401)
14. Rogers MF, Rutherford GW, Alexander SR, et al. A population-based study of he-molytic- uremic syndrome in Oregon, 1979-1982. Am J Epidemiol. 1986;123(1): 137-142. (Pubitemid 16189706)
15. Banatvala N, Griffin PM, Greene KD, et al Hemolytic Uremic Syndrome Study Collaborators. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis. 2001;183(7):1063-1070. (Pubitemid 32230954)
16. Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection. 1999;27(6):341-347.
17. Aquino J, Custer JW, Rau RE, eds. Hematology . In The Harriet Lane Handbook. 18th ed. Philadelphia, PA: Elsevier Mosby; 2009:359-386.
18. Jernigan SM, Waldo FB. Racial incidence of hemolytic uremic syndrome. Pediatr Nephrol. 1994;8(5):545-547. (Pubitemid 24287863)
19. Barrett TJ, Green JH, Griffin PM, Pavia AT, Osteroff SM, Wachsmuth IK. Enzymelinked immunoabsorbant assays for detecting antibodies to Shiga-like toxin I, Shigalike toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol. 1991;23(5):189-195.
20. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001;153(10):1016- 1020.
21. Espié E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non- O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J. 2008;27(7):595-601.
22. Proulx F, Sockett P. Prospective surveillance of Canadian children with the haemolytic uraemic syndrome. Pediatr Nephrol. 2005;20(6):786-790. (Pubitemid 40663164)
23. Schifferli A, von Vigier RO, Fontana M, et al Swiss Pediatric Surveillance Unit. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003. Eur J Pediatr. 2010;169(5):591-598.
24. Tozzi AE, Caprioli A, Minelli F, et al Hemolytic Uremic Syndrome Study Group. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis. 2003;9(1):106-108. (Pubitemid 36110210)
25. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolyticuremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186(4):493-500. (Pubitemid 34876258)
26. Lynn RM, O'Brien SJ, Taylor CM, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis. 2005;11(4):590-596. (Pubitemid 40462910)
27. Karch H, Janetzki-Mittmann C, Aleksic S, Datz M. Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J Clin Microbiol. 1996;34(3):516-519. (Pubitemid 26065766)
28. Brooks JT, Sowers EG, Wells JG, et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis. 2005;192(8): 1422-1429. (Pubitemid 41401157)
29. Ethelberg S, Olsen KE, Scheutz F, et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis. 2004;10(5):842-847. (Pubitemid 38552751)
30. Bielaszewska M, Mellmann A, Zhang W, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis. 2011;11(9):671-676.
31. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162(2):553-556. (Pubitemid 20239981)
32. Werber D, Mason BW, Evans MR, Salmon RL. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis. 2008;46(8):1189-1196. (Pubitemid 351589901)
33. Hickey CA, Beattie TJ, Cowieson J, et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med. 2011;165(10):884-889.
34. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342(26):1930-1936. (Pubitemid 30419087)
35. Elliott EJ, Robins-Browne RM, O'Loughlin EV, et al Contributors to the Australian Paediatric Surveillance Unit. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child. 2001;85 (2):125-131.
36. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics. 2006;117(5):1656-1662. (Pubitemid 46071393)
37. Ariceta G, Besbas N, Johnson S, et al European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009;24(4):687-696.
38. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol. 2008;23(11):1951-1956.
39. Banerjee R, Hersh AL, Newland J, et al; Emerging Infections Network Hemolytic- Uremic Syndrome Study Group. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011; 30(9):736-739.
40. Petti CA, Ignatius Ou SH, Sexton DJ. Acute terminal ileitis associated with pneumococcal bacteremia: case report and review of pneumococcal gastrointestinal diseases. Clin Infect Dis. 2002;34(10):E50-E53.
41. Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS-more than just another trigger? Pediatr Nephrol. 2011;26(1):3-5.
42. Rongnoparat C, Panpanit R. Hemolytic uremic syndrome associated with shigellosis: report of two cases. Southeast Asian J Trop Med Public Health. 1987;18 (2):226-228. (Pubitemid 18084437)
43. Larke RP, Preiksaitis JK, Devine RD, Harley FL. Haemolytic uraemic syndrome: evidence of multiple viral infections in a cluster of ten cases. J Med Virol. 1983; 12(1):51-59. (Pubitemid 13077613)
44. Rooney N, Variend S, Taitz LS. Haemolytic uraemic syndrome and pseudomembranous colitis. Pediatr Nephrol. 1988;2(4):415-418.
45. Bogdanović R, Cobeljić M, Marković M, et al. Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis. Pediatr Nephrol. 1991;5(3): 293-295.
46. Ornt DB, Griffin PM, Wells JG, Powell KR. Hemolytic uremic syndrome due to Escherichia coli O157: H7 in a child with multiple infections. Pediatr Nephrol. 1992; 6(3):270-272.
47. Shepherd AB, Palmer AL, Bigler SA, Baliga R. Hemolytic uremic syndrome associated with group A beta-hemolytic streptococcus. Pediatr Nephrol. 2003;18(9): 949-951. (Pubitemid 37121632)
48. Izumi T, Hyodo T, Kikuchi Y, et al. An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome. Am J Kidney Dis. 2005;46(4):e59-e63. (Pubitemid 41383965)